Pancragen in diabetic rats: blood glucose and mesenteric capillary outcomes
Animal research · 2007
- What was studied
- Wistar rats with streptozotocin-induced diabetes. The abstract leaves arm sizes, doses and observation time unspecified.
- Main finding
- The authors reported lower blood glucose during oral treatment and normalization of endothelial adhesion measures after intramuscular treatment. Capillary permeability was unchanged with intramuscular treatment.
Reported findings and study design
Findings described in words
Oral and intramuscular Pancragen in Wistar rats with experimental streptozotocin diabetes.
Population or model Wistar rats with streptozotocin-induced diabetes. The abstract leaves arm sizes, doses and observation time unspecified.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Blood glucose | Decreased during oral treatment according to the authors. | |
| Mesenteric capillary endothelial adhesion | Returned toward the normal range with intramuscular treatment according to the authors. | |
| Capillary permeability | Intramuscular treatment produced no reported change. |
Source for these results ↗ · Reviewed 2026-11-16
Study limitations and source details
Study limitations
- The original abstract gives qualitative results and leaves the size of the changes unspecified.
- The related pancreatic morphology paper used the same diabetic model. Animal reuse is possible, so its arm sizes and doses cannot be assigned to this vascular report.
Source details
Original journal report
Indexed original abstract. Numerical outcome tables remain unavailable.
Sources checked
Citation
V. Kh. Khavinson, N. A. Gavrisheva, V. V. Malinin, S. G. Chefu, E. L. Trofimov. Pancragen in diabetic rats: blood glucose and mesenteric capillary outcomes Bulletin of Experimental Biology and Medicine. 2007;144(4):559–562.
Study source ↗ · DOI 10.1007/s10517-007-0377-3 · Bibliography entry · Link to this summary